Website Metrics and Site Statistics by NextSTAT PCRM >> Research >> Beyond Animal Research >> Spinal Cord Injury Experiments on Animals
PCRM Home
Media CenterHealthResearchAbout PCRM CatalogJoin Us
Physicians Committee for Responsible Medicine
 

Fact sheet:
Priorities for Research
in Spinal Cord Injury

Beyond Animal Research Archive

 

Animal Experimentation Issues


Beyond Animal Research

By Kristie Stoick, M.P.H.
May 2005

Spinal Cord Injury Experiments on Animals

Every year, approximately 10,000 people in the United States suffer some sort of spinal cord injury; many thereafter are confined to wheelchairs and forced to adapt to a host of medical challenges.1 Decreased activity can lead to bone and muscle loss, weight gain, cardiovascular disease, diabetes mellitus, and circulatory dysfunction. Others experience idiopathic pain sensations, muscle spasticity, and pressure ulcers on the skin. Finally, most have functional difficulties with the digestive, excretory, and reproductive systems.

Unfortunately, the tragic results of spinal cord injuries (SCI) are in fact two-fold. In an effort to help people with SCI, many researchers are attempting to create animal “models” of injured humans. Over the past few decades, much effort and expense has been spent creating sophisticated impaction devices and other injury techniques designed to eliminate variability and deliver a reproducible spinally injured animal. Every year, thousands of animals are given spinal cord injuries through blunt trauma, loss of blood flow, or surgical transection, then treated or dissected in hopes that a cure will be found.

Some of these projects have seemed to bear fruit—at first. Scientists have managed to re-grow damaged neural tissue in the spinal cords of rats,2-4 see cats with completely cut spinal cords walk again, determine detailed information about neural connectivity in macaques,5 and prevent secondary damage to neural tissue after injury.6 Thousands of animals have been injured and evaluated.

Unfortunately, and perhaps predictably, not one of these experiments has actually led to a cure or effective treatment for human spinal cord injury. Out of nearly two dozen therapies suggested to be effective in non-human animals,7 only one (methylprednisolone) proved helpful to injured humans.8 Even the effectiveness of methylprednisolone is now being called into serious question by practicing clinicians.

Perhaps the most salient reasons for this failure are related to anatomy—each species has a unique spinal orientation, movement kinetics, and neural anatomy. Furthermore, every human spinal injury comes with its own set of physical, neurochemical, and histological pathologies that cannot be properly duplicated in a laboratory setting.

On the other hand, human research methods have produced promising results, and others are worth a closer look. Here’s a sampling:

  • A group of London researchers found that damage to spinal cord neurons in cell culture was prevented by inhibiting a specific nuclear enzyme apparently involved in peroxynitrite-induced cell damage after injury.9
  • A procedure to create human motoneuron cell lines in culture was developed in 2000.10 Researchers found the cloned neurons displayed normal neuronal processes, including immunoreactivity and action potential firing, and researchers were also able to coax clonal precursor cells into multiple types of spinal cord neurons.10
  • Non-invasive imaging techniques, such as PET, SPECT, and fMRI, as well as more invasive cerebrospinal fluid studies, can be used to visualize neural pathology at various time points after injury and monitor the effects of experimental therapies. By studying neuromuscular connections in both uninjured and spinal cord-injured patients, University of Miami School of Medicine scientists have found mechanisms in the spinal cord that are responsible for coordinating opposing muscle movements.11
  • In Miami, researchers are collaborating on the Human Spinal Cord Injury Model project. This project is studying spinal cord injured patients, both pre- and post-mortem, to build a more realistic understanding of human spinal cord injury. Post-mortem spinal cord tissue can be compared to MRIs to determine histopathological changes in cells and tissues.12,13

Researchers, clinicians, and patients alike agree that a more directed effort to establish human clinical research projects is needed. While success in restoring functional endpoints has been realized in a number of areas,14-23 more investment in this avenue of research is needed. Only then will true success be realized.

Kristie Stoick, M.P.H., is a PCRM research analyst.

References:
1. Reyes O, Sosa I, Kuffler DP Neuroprotection of spinal neurons against blunt trauma and ischemia. P R Health Sci J 2003;22(3):277-86.
2. Li Y and Raisman G. Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord. J Neurosci 1994;14:4050-63.
3. Richardson PM, Issa VMK, Aguayo AJ. Regeneration of long spinal axons in the rat. J Neurocytology 1984;13:165-82.
4. Li WWY, Yew DTW, Chuah MI, Leung PC, Tsang DSC. Axonal sprouting in the hemisected adult rat spinal cord. Neurosci 1994;61(1):133-9.
5. Galea MP and Darian-Smith I. Multiple corticospinal neuron populations in the macaque monkey are specified by their unique cortical origins, spinal terminations, and connections. Cereb Cortex 1994;4:166-94.
6. Yu CG, Jimenez O, Marcillo AE, Weider B, Bangerter K, Dietrich WD, Castro S, Yezierski RP. Beneficial effects of modest systemic hypothermia on locomotor function and histopathological damage following contusion-induced spinal cord injury in rats. J Neurosurg 2000;93(1 Suppl):85-93.
7. Maiman D. Symposium on spinal cord injury models: Introduction. J Am Paraplegia Soc 1988;11:23-25.
8. Dobkin BH and Havton LA. Basic advances and new avenues in therapy of spinal cord injury. Annu Rev Med 2004;55:255-82.
9. Scott GS, C Szabo, DC Hooper. Poly(ADP-ribose) polymerase activity contributes to peroxynitrite induced spinal cord neuronal cell death in vitro. J Neurotrauma 2004;21(9):1255-63
10. Li R, S Thode, N Richard, J Pardinas, MS Rao, DW Sah. Motoneuron differentiation of immortalized human spinal cord cell lines. J Neurosci Res 2000;59(3):342-52.
11. Perez MA, EC Field-Fote. Impaired posture-dependent modulation of disynaptic reciprocal Ia inhibition in individuals with incomplete spinal cord injury. Neurosci Lett 2003;341(3):225-8.
12. Emery E, P Aldana, MB Bunge, W Puckett, A Srinivasan, RW Keane, J Bethea, AD Levi. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998; 89(6):911-20.
13. Bruce JH, MD Norenberg, S Kraydieh, W Puckett, A Marcillo, D Dietrich. Schwannosis: role of gliosis and proteoglycan in human spinal cord injury. J Neurotrauma 2000;17(9):781-8.
14. Herman, R, J He, S D’Luzansky, W Willis, S. Dilli. Spinal cord stimulation facilitates functional walking in a chronic incomplete spinal cord injured. Spinal Cord 2002;40(2):65-8.
15. Carhart MR, J He, R Herman, S D’Luzansky, WT Willis. Epidural spinal-cord stimulation facilitates recovery of function walking following incomplete spinal-cord injury. IEEE Trans Neural Syst Rehabil Eng 2004;12(1):32-42.
16. Widerstrom-Noga EG and DC Turk. Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristics. Spinal Cord 2003;41(11):600-9.
17. Nance PW, J Bugaresti, K Shellenberger, W Sheremata, A Martinez-Arizala. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American tizandine study group. Neurology 1994;44(11 Suppl 9):S44-51.
18. Mathew KM, G Ravichandran, K May, K Morsley. The biophyschosocial model and spinal cord injury. Spinal Cord 2001;39(12):644-9.
19. Raghavan P, WA Raza, YS Ahmed, MA Chamberlain. Prevalence of pressure sores in a community sample of spinal injury patients. Clin Rehabil 2003;17(8):879-84.
20. Sprigle S, M Linden, D McKenna, K Davis, B Riordan. Clinical skin temperature measurement to predict incipient pressure ulcers. Adv Skin Wound Care 2001;14(3):133-7.
21. Moussavi RM, HM Garza, SG Eisele, G Rodriguez, DH Rintala. Serum levels of vitamins A, C, and E in persons with chronic spinal cord injury living in the community. Arch Phys Med Rehabil 2003;84(7):1061-7.
22. Korsten MA, NR Fajardo, AS Rosman, GH Creasey, AM Spungen, WA Bauman. Difficulty with evacuation after spinal cord injury: Colonic motility during sleep and effects of abdominal wall stimulation. J Rehabil Res Dev 2004;41(1):95-100.
23. Creasey GH, JH Grill, M Korsten, U HS, R Betz, R Anderson, J Walter, Implanted Neuroprosthesis Research group. An implantable neuroprosthesis for restoring bladder and bowel control to patients with spinal cord injuries: a multicenter trial. Arch Phys Med Rehabil 2001;82(11):1512-9.


Media Center | Health | Research | About PCRM | Catalog | Join Us | Search | Site Index | Home

The site does not provide medical or legal advice. This Web site is for information purposes only.
Full Disclaimer
| Privacy Policy

Physicians Committee for Responsible Medicine 5100 Wisconsin Ave., Suite 400
Washington, DC 20016